Evaluation of Killing Activity of Expanded Natural Killer Cells From Blood in Patients With Pancreatic Cancer

Inclusion Criteria

• •The patient who is admitted to the pancreatic surgery department for the treatment of pancreas tumor
• •Patients must have the ability to read, understand, and sign an informed consent and must be willing to comply with study treatment and follow-up.
• •Life expectancy of at least 6 months based on discretion of treating
• •Adequate hematologic function defined by the following laboratory parameters: Hemoglobin \> 100, Platelet count \> 100 and Absolute granulocyte count \> 1.5.